title: Comparative study of the effects of three angiotensin converting enzyme inhibitors on the cough reflex.
abstract: To compare the effects of three different angiotensin converting enzyme (ACE) inhibitors on the cough reflex, capsaicin and citric acid challenge tests were done in normal subjects and hypertensive patients before and after administration of delapril, captopril, or enalapril. Two groups of 7 normal subjects (single dose study: 15 mg delapril v 18.75 mg captopril or 2.5 mg enalapril) and a group of 6 mildly hypertensive patients (1 week study: cross-over administration of 30 mg/day delapril, 37.5 mg/day captopril, or 5 mg/day enalapril) were studied. Another group of 6 patients with essential hypertension was treated with three ACE inhibitors for 4 weeks in a randomized order, with a 2 week washout period between active therapies. Aerosols of 1 mumol/L and 3 mumol/L capsaicin and 0.68% citric acid in 0.9% NaCl were generated by an ultrasonic nebulizer, and the frequency of cough was counted during inhalation. Delapril treatment resulted in substantially fewer patients with a significant increase (greater than or equal to 4 coughs during treatment than during the control period) in the frequency of cough than did captopril treatment. In the 1 and 4 week studies, enalapril and captopril had substantially more occurrences of significantly increased capsaicin-induced cough than did delapril. These results indicate that delapril has the least cough stimulatory effect among these ACE inhibitors, which may be clinically beneficial.
authors.affiliation: Department of Geriatric Medicine, Osaka University Medical School, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Ogihara
authors.forename: H
authors.initials: H
authors.lastname: Mikami
authors.forename: K
authors.initials: K
authors.lastname: Katahira
authors.forename: A
authors.initials: A
authors.lastname: Otsuka
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D002211:Capsaicin / Q000008:administration & dosage / Q000009:adverse effects; D002216:Captopril / Q000494:pharmacology; D002951:Citrates / Q000008:administration & dosage / Q000009:adverse effects; D019343:Citric Acid; D003371:Cough / Q000139:chemically induced / Q000503:physiopathology*; D004656:Enalapril / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D007189:Indans / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012018:Reflex / Q000187:drug effects*
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002951:Citrates; D007189:Indans; D019343:Citric Acid; D004656:Enalapril; D002216:Captopril; D002211:Capsaicin; C047759:delapril